GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
This Quarter Return
+15.43%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.95B
AUM Growth
+$2.95B
(+6.5%)
Cap. Flow
-$90.6M
Cap. Flow
% of AUM
-3.07%
Top 10 Holdings %
Top 10 Hldgs %
32.93%
Holding
212
New
21
Increased
70
Reduced
88
Closed
32
Top Buys
| 1 |
Sprout Social
SPT
|
$35M |
| 2 |
Porch Group
PRCH
|
$32.4M |
| 3 |
Enphase Energy
ENPH
|
$31.4M |
| 4 |
Bright Horizons
BFAM
|
$21.2M |
| 5 |
QuidelOrtho
QDEL
|
$19.9M |
Top Sells
| 1 |
Paylocity
PCTY
|
$64.7M |
| 2 |
VRTU
Virtusa Corporation
VRTU
|
$47.2M |
| 3 |
Chegg
CHGG
|
$32.9M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$31.9M |
| 5 |
Digital Turbine
APPS
|
$28.2M |
Sector Composition
| 1 | Technology | 36.54% |
| 2 | Healthcare | 17.87% |
| 3 | Industrials | 13.82% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Communication Services | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEWR
151
DELISTED
New Relic, Inc.
NEWR
| $2.09M | 0.07% |
37,024
-5,716
| -13% | -$322K |
|
152
Xeris Biopharma Holdings
XERS
$1.27B
| $2.05M | 0.07% |
346,428
+6,025
| +2% | +$35.7K |
|
|
AKTS
153
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $2.01M | 0.07% |
245,903
+80,924
| +49% | +$660K |
|
|
BLDP
154
Ballard Power Systems
BLDP
$568M
| $2M | 0.07% |
+132,261
| New | +$2M |
|
155
Silicon Laboratories
SLAB
$4.3B
| $1.95M | 0.07% |
19,972
-3,525
| -15% | -$345K |
|
|
QTS
156
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.91M | 0.06% |
30,291
-5,150
| -15% | -$325K |
|
|
NPTN
157
DELISTED
NEOPHOTONICS CORP
NPTN
| $1.9M | 0.06% |
311,140
+10,802
| +4% | +$65.8K |
|
|
PFPT
158
DELISTED
Proofpoint, Inc.
PFPT
| $1.87M | 0.06% |
17,740
-3,424
| -16% | -$361K |
|
|
ICPT
159
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.85M | 0.06% |
44,625
-5,717
| -11% | -$237K |
|
160
Xenon Pharmaceuticals
XENE
$2.99B
| $1.76M | 0.06% |
158,704
+47,705
| +43% | +$528K |
|
|
RDNW
161
RideNow Group, Inc. Class B Common Stock
RDNW
$138M
| $1.74M | 0.06% |
65,117
| – | – |
|
162
Cidara Therapeutics
CDTX
$1.61B
| $1.6M | 0.05% |
28,136
+225
| +0.8% | +$12.8K |
|
163
Argan
AGX
$3.1B
| $1.47M | 0.05% |
13,998
+6,636
| +90% | +$699K |
|
164
Intellia Therapeutics
NTLA
$1.26B
| $1.47M | 0.05% |
74,034
-2,271
| -3% | -$45.2K |
|
165
AXT Inc
AXTI
$142M
| $1.43M | 0.05% |
+233,148
| New | +$1.43M |
|
|
AERI
166
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.19M | 0.04% |
101,249
-64,245
| -39% | -$756K |
|
|
CNTG
167
DELISTED
Centogene N.V. Common Shares
CNTG
| $1.14M | 0.04% |
+120,823
| New | +$1.14M |
|
168
Newmark Group
NMRK
$3.07B
| $1.13M | 0.04% |
260,613
-723,076
| -74% | -$3.12M |
|
169
Sangamo Therapeutics
SGMO
$161M
| $1.07M | 0.04% |
113,388
-10,563
| -9% | -$99.9K |
|
|
NBRV
170
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $750K | 0.03% |
5,632
+99
| +2% | +$13.2K |
|
171
Laird Superfood
LSF
$61.5M
| $720K | 0.02% |
+15,689
| New | +$720K |
|
|
DMTK
172
DELISTED
DermTech, Inc. Common Stock
DMTK
| $672K | 0.02% |
+56,206
| New | +$672K |
|
173
Biomerica
BMRA
$7.26M
| $622K | 0.02% |
11,216
+8,068
| +256% | +$447K |
|
174
Hudson Technologies
HDSN
$447M
| $618K | 0.02% |
537,743
+445,333
| +482% | +$512K |
|
|
OTIC
175
DELISTED
Otonomy, Inc.
OTIC
| $617K | 0.02% |
152,384
+3,094
| +2% | +$12.5K |
|